Warning: The NCBI web site requires JavaScript to function. more...
Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases.
Nathan DG, Orkin SH.
Genome Med. 2009 Dec 9;1(12):114.
Related citations
Treatment of lysosomal storage disorders : progress with enzyme replacement therapy.
Rohrbach M, Clarke JT.
Drugs. 2007;67(18):2697-716. Review.
Fabry's disease: long-term study of a family.
Arias Martínez N, Barbado Hernández FJ, García Consuegra J, López Rodríguez M, Gil Guerrero L, Gómez-Cerezo J, Casal Esteban V, Vázquez Rodríguez JJ.
Eur J Intern Med. 2004 Jul;15(4):210-215.
[Enzyme replacement therapy in Pompe's disease].
Merk T, Wibmer T, Schumann C, Krüger S.
Med Klin (Munich). 2007 Jul 15;102(7):570-3. German.
Lysosomal storage disorders.
Vellodi A.
Br J Haematol. 2005 Feb;128(4):413-31. Review.
Therapeutic approaches to lysosomal storage diseases.
Kaye EM.
Curr Opin Pediatr. 1995 Dec;7(6):650-4. Review.
[Neurological presentations of lysosomal diseases in adult patients].
Sedel F, Turpin JC, Baumann N.
Rev Neurol (Paris). 2007 Oct;163(10):919-29. Review. French.
Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
Mignani R, Cagnoli L.
J Nephrol. 2004 May-Jun;17(3):354-63. Review.
New prospects for the treatment of lysosomal storage diseases.
Schiffmann R, Brady RO.
Drugs. 2002;62(5):733-42. Review.
[Pompe's disease. Part II. Treatment strategies and enzyme replacement].
Illés Z, Várdi Visy K.
Ideggyogy Sz. 2009 Sep 30;62(9-10):299-307. Review. Hungarian.
Enzyme replacement therapy in an infant with Pompe's disease with severe cardiomyopathy.
Tanzer F, Buyukkayhan D, Cansu Mutlu E, Kalender Korkmaz F.
J Pediatr Endocrinol Metab. 2009 Dec;22(12):1159-62.
[Gaucher's disease--ocular manifestation and treatment].
Filipek E, Koraszewska-Matuszewska B.
Klin Oczna. 2006;108(7-9):357-60. Review. Polish.
Cardiomyopathy in Pompe's disease.
Fayssoil A.
Eur J Intern Med. 2008 Jan;19(1):57-9. Epub 2007 Nov 26. Review.
Gaucher's disease: a review for the internist and hepatologist.
Niederau C, Häussinger D.
Hepatogastroenterology. 2000 Jul-Aug;47(34):984-97. Review.
Pompe's disease.
van der Ploeg AT, Reuser AJ.
Lancet. 2008 Oct 11;372(9646):1342-53. Review.
Enzyme replacement therapy for Gaucher's disease: the early Canadian experience.
MacKenzie JJ, Amato D, Clarke JT.
CMAJ. 1998 Nov 17;159(10):1273-8.
[Ocular findings in Fabry's disease].
Kuzman T, Juri J, Mrsić M, Jeren-Strujić B, Mandić Z, Sikić J.
Acta Med Croatica. 2006;60(2):163-6. Croatian.
New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy.
Beck M.
Hum Genet. 2007 Mar;121(1):1-22. Epub 2006 Nov 7. Review.
[Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
Fabrega S, Lehn P.
J Soc Biol. 2002;196(2):175-81. Review. French.
Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders.
Butters TD.
Expert Opin Pharmacother. 2007 Mar;8(4):427-35. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on